Archive
Past newsletters of MDDR.
Tuesday, 7 July 2026
Pharmacist prescribing evidence questioned, New split billing regulations proposed, AMA presidential candidates announced
A new report from the Sax Institute reveals significant uncertainties regarding the evidence supporting pharmacist-led prescribing in Austra
Monday, 6 July 2026
PCOS renaming proposal discussion, Long-term care workforce crisis, State surveillance of reproductive tech
The authors of a correspondence in The Lancet address the proposal to rename polycystic ovary syndrome (PCOS) to polyendocrine metabolic ova
Sunday, 5 July 2026
PCOS name change proposal, WHO prioritises rehabilitation, US reduces PEPFAR support
Helena J Teede and colleagues propose renaming polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) based on
Saturday, 4 July 2026
Sublocade PBS withdrawal concerns, New GP incentive for veterans, NSW health funding accountability call
Indivior will withdraw Sublocade, a slow-release buprenorphine injection, from the PBS in January, citing a commercial decision. This move h
Friday, 3 July 2026
Nurse prescribers gain PBS authority, Intranasal adrenaline neffy added to PBS, PBS pricing dispute for MS therapies
Registered nurse prescribers in Australia gained the authority to prescribe Pharmaceutical Benefits Scheme (PBS) medicines, marking a signif
Thursday, 2 July 2026
NSW THC driving law proposal, New Medicare bulk billing campaign, Lancet calls for primary care reforms
The Minns government in New South Wales has proposed new driving laws for patients using THC-containing medicinal cannabis products. The Bil
Wednesday, 1 July 2026
AMA opposes pharmacist prescribing, Funding boost for ADHD assessments, New bulk-billing clinics in Canberra
The Australian Medical Association (AMA) has expressed strong opposition to the Pharmacy Board of Australia's draft prescribing endorsement
Tuesday, 30 June 2026
Pharmacy roles could reduce admissions, New bulk billing policy details, Cohealth apologises for service issues
The Pharmacy Guild of Australia claims that expanding pharmacists' scope of practice could prevent around 30,000 hospital admissions annuall
Monday, 29 June 2026
AI in mammography trial results, Citizen project tackles heat risks, Literary magazines and medicine
The MASAI trial demonstrates that an artificial intelligence (AI)-supported workflow in mammography screening shows non-inferiority for inte
Sunday, 28 June 2026
AI in mammography screening, Chemotherapy drug shortages in India, Misinformation as a health risk
The MASAI trial concludes that AI-supported mammography screening can efficiently improve screening performance and may be considered for im